A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/21036667

Download in:

View as

General Info

PMID
21036667